Breast Cancer Clinical Trial
Official title:
Obesity Reduction Black Intervention Trial (ORBIT)
RATIONALE: A diet and physical activity program followed by a weight-loss maintenance
program may help obese black women lose weight. It is not yet known whether a weight-loss
program is more effective than a general health education program in helping obese black
women lose weight. Weight loss may reduce a person's risk of developing cancer.
PURPOSE: This randomized phase III trial is studying a weight-loss program to see how well
it works in helping obese black women lose weight.
OBJECTIVES:
Primary
- To estimate the effectiveness of a 24-week diet and physical activity intervention and
a 1-year maintenance intervention designed to produce and maintain weight loss in obese
black women.
- To estimate the effect of these interventions on changes in fasting serum insulin,
glucose, and free IGF-1, IGFBP-1, and IGFBP-2 levels as well as total IGF-1 and IGFBP-3
levels.
Secondary
- To compare changes in dietary consumption of total calories, total fat, fruits,
vegetables, and fiber as well as physical activity in participants undergoing a
weight-loss intervention vs a control intervention.
- To compare changes in knowledge, attitudes, self-efficacy, and social support related
to diet, physical activity, and weight loss in participants undergoing a weight-loss
intervention vs a control intervention.
- Assess the efficacy of a weight-loss intervention mechanism and the association between
weight loss and weight loss maintenance with potential biologic mediators of breast
cancer risk.
OUTLINE: Participants are randomized to 1 of 2 intervention arms.
- Arm I (weight-loss intervention): Participants undergo a combined weight-loss
intervention (diet and physical activity) over 24 weeks comprising individualized
sessions with an interventionist once monthly and group sessions twice weekly. During
the group sessions, participants receive information about diet, physical activity, and
weight loss and take part in exercise classes. Participants receive handouts,
food-measuring tools, and pedometers. Participants also discuss goal setting and
problem solving. During the individualized sessions, participants undergo motivational
interviewing (MI) to assess their individual needs and to motivate them to make or
sustain behavioral changes.
Beginning 1 month after completion of the combined weight-loss intervention, participants
undergo a weight-loss maintenance intervention over 12 months. Participants continue their
exercise classes twice weekly and receive a copy of the aerobic exercise class videotape for
use at home. Prior to each exercise session, participants may share their weight-loss
experiences (e.g., successes, struggles) or a motivational or informational story, article,
or prayer with other group members. Participants also receive weekly newsletters that
include information presented in the original weight-loss intervention, opportunities in the
community for physical activity (e.g., ice skating, swimming, or local walks), and further
advice on maintaining weight loss. Participants undergo 4 MI sessions over the telephone
that address diet, physical activity, and weight-loss maintenance strategies. The MI
sessions also provide an opportunity for individualized problem solving.
- Arm II (control intervention): Participants undergo a control intervention over 24
weeks comprising weekly newsletters on general health topics, such as first aid,
smoking cessation, cancer screening, and disease prevention, and monthly general health
classes that demonstrate information conveyed in the newsletter (e.g., first-aid
techniques).
After completion of the control intervention, participants undergo a control maintenance
intervention over 12 months comprising a monthly newsletter on general health topics. After
completion of the maintenance intervention, participants undergo 10 intervention sessions
and receive the same study-related materials (handouts, food-measuring tools, and
pedometers) as in arm I.
Blood samples are collected at baseline, 24 weeks, and 18 months for laboratory biomarker
studies. Samples are analyzed for insulin levels by radioimmunoassay, glucose
concentrations, and total and free IGF-1, IGFBP-1, IGFBP-2, and IGFBP-3 by enzyme-linked
immunoassay.
Participants complete questionnaires at baseline, 24 weeks, and 18 months to assess diet,
physical activity, cognitive measures (attitudes, beliefs, and self-efficacy), social
support, and environmental measures.
;
Allocation: Randomized
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |